CARLSBAD, Calif.--(BUSINESS WIRE)--ArtVentive Medical Group, Inc. (OTC Bulletin Board AVTD) announced today that the Company conducted its first animal study of its next generation of the ArtVentive Endoluminal Occlusion System (EOS™ Gen II). The EOS™ is designed for use in the peripheral vasculature and offers immediate and permanent vessel occlusion in arterial and venous settings.
